Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 976 AL 990

Connecting vascular aging and frailty in Alzheimer's disease

Sabbatinelli J, Ramini D, Giuliani A, Recchioni R, Spazzafumo L, Olivieri F.

Mech Ageing Dev. 2021 Apr;195:111444. doi: 10.1016/j.mad.2021.111444. Epub 2021 Feb 1.

Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology

Filippone A, Praticò D.

Ann Neurol. 2021 Jul;90(1):4-14. doi: 10.1002/ana.26042. Epub 2021 Feb 25.

Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes

Köbe T, Binette AP, Vogel JW, Meyer PF, Breitner JCS, Poirier J, Villeneuve S; Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group.

Neuroimage. 2021 May 1;231:117832. doi: 10.1016/j.neuroimage.2021.117832. Epub 2021 Feb 4.

Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies

Londzin P, Zamora M, Kąkol B, Taborek A, Folwarczna J.

Nutrients. 2021 Feb 6;13(2):537. doi: 10.3390/nu13020537.

GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease

Jiménez-Balado J, Eich TS.

Semin Cell Dev Biol. 2021 Aug;116:146-159. doi: 10.1016/j.semcdb.2021.01.005. Epub 2021 Feb 9.

Cannabinoids for Agitation in Alzheimer's Disease

Outen JD, Burhanullah MH, Vandrey R, Amjad H, Harper DG, Patrick RE, May RL, Agronin ME, Forester BP, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Dec;29(12):1253-1263. doi: 10.1016/j.jagp.2021.01.015. Epub 2021 Jan 27.

Alzheimer's Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models

Carranza-Naval MJ, Vargas-Soria M, Hierro-Bujalance C, Baena-Nieto G, Garcia-Alloza M, Infante-Garcia C, Del Marco A.

Biomolecules. 2021 Feb 10;11(2):262. doi: 10.3390/biom11020262.

Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study

Wang J, Guo X, Lu W, Liu J, Zhang H, Quan Q, Su H, Ma L, Gao F, Qu Q.

J Alzheimers Dis. 2021;80(2):673-681. doi: 10.3233/JAD-201381.

Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods

Ma D, Yee E, Stocks JK, Jenkins LM, Popuri K, Chausse G, Wang L, Probst S, Beg MF.

J Alzheimers Dis. 2021;80(2):715-726. doi: 10.3233/JAD-201591.

What day is today? Cognitive capacity and the risk of incident dementia in the context of integrated care for older people (ICOPE Step 1)

González-Bautista E, de Souto Barreto P, Andrieu S, Rolland Y, Vellas B; MAPT/DSA group.

Aging Clin Exp Res. 2021 Nov;33(11):3135-3139. doi: 10.1007/s40520-021-01803-4. Epub 2021 Feb 13.

Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials

Lu M, Pontecorvo MJ, Devous MD Sr, Arora AK, Galante N, McGeehan A, Devadanam C, Salloway SP, Doraiswamy PM, Curtis C, Truocchio SP, Flitter M, Locascio T, Devine M, Zimmer JA, Fleisher AS, Mintun MA; AVID Collaborators.

JAMA Neurol. 2021 Apr 1;78(4):445-453. doi: 10.1001/jamaneurol.2020.5505.

Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes

Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AMH, Franklin RJM, Johnson T, Estrada K, Gaffney DJ, Beltrao P, Bassett A.

Nat Genet. 2021 Mar;53(3):392-402. doi: 10.1038/s41588-020-00776-w. Epub 2021 Feb 15.

Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation

Rivers-Auty J, Tapia VS, White CS, Daniels MJD, Drinkall S, Kennedy PT, Spence HG, Yu S, Green JP, Hoyle C, Cook J, Bradley A, Mather AE, Peters R, Tzeng TC, Gordon MJ, Beattie JH, Brough D, Lawrence CB.

J Neurosci. 2021 Mar 31;41(13):3025-3038. doi: 10.1523/JNEUROSCI.1980-20.2020. Epub 2021 Feb 17.

AVP-786 as a promising treatment option for Alzheimer's Disease including agitation

Khoury R, Marx C, Mirgati S, Velury D, Chakkamparambil B, Grossberg GT.

Expert Opin Pharmacother. 2021 May;22(7):783-795. doi: 10.1080/14656566.2021.1882995. Epub 2021 Feb 26.

Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?

Liguori C, Cremascoli R, Maestri M, Fernandes M, Izzi F, Tognoni G, Scarpina F, Siciliano G, Mercuri NB, Priano L, Bonanni E, Placidi F.

Sleep Breath. 2021 Dec;25(4):2135-2139. doi: 10.1007/s11325-021-02320-4. Epub 2021 Feb 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias